JWH-198

JWH-198 is a synthetic cannabinoid from the naphthoylindole family, which acts as a full agonist at both the CB₁ and CB₂ cannabinoid receptors, but with moderate selectivity for CB₂. It was discovered by and named after Dr. John W. Huffman.

Chemistry

JWH-198 is part of the naphthoylindole family of synthetic cannabinoids. It is structurally related to other synthetic cannabinoids including JWH-018, JWH-073, and JWH-200. The compound is a full agonist at both the CB₁ and CB₂ cannabinoid receptors, but it has moderate selectivity for the CB₂ receptor.

Pharmacology

As a full agonist at the CB₁ and CB₂ receptors, JWH-198 can produce a wide range of effects similar to those of cannabis. These effects can include relaxation, euphoria, and altered perception. However, because it is a synthetic compound, the effects of JWH-198 can be more potent and unpredictable than those of natural cannabis.

Legal Status

The legal status of JWH-198 varies by country and region. In some places, it is classified as a controlled substance due to its potential for abuse and its psychoactive effects. In others, it may be legal to possess and use. It is important to check local laws before possessing or using this substance.

See Also

• Cannabinoid
• Cannabinoid receptor
• Synthetic cannabinoids
• JWH-018
• JWH-073
• JWH-200

JWH-198 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia